bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies Market Cap : 2.508M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 2.508M |
| November 17, 2026 | 2.252M |
| November 16, 2026 | 2.333M |
| November 13, 2026 | 2.566M |
| November 12, 2026 | 2.730M |
| November 11, 2026 | 2.829M |
| November 10, 2026 | 2.788M |
| November 09, 2026 | 2.636M |
| November 06, 2026 | 3.167M |
| November 05, 2026 | 3.033M |
| November 04, 2026 | 3.418M |
| November 03, 2026 | 3.722M |
| November 02, 2026 | 1.352M |
| October 30, 2026 | 1.316M |
| October 29, 2026 | 1.370M |
| October 28, 2026 | 1.420M |
| October 27, 2026 | 1.338M |
| October 26, 2026 | 1.280M |
| October 23, 2026 | 1.266M |
| October 22, 2026 | 1.434M |
| October 21, 2026 | 1.614M |
| October 20, 2026 | 1.655M |
| October 19, 2026 | 1.587M |
| October 16, 2026 | 1.687M |
| October 15, 2026 | 1.791M |
| Date | Value |
|---|---|
| October 14, 2026 | 1.610M |
| October 13, 2026 | 1.639M |
| October 12, 2026 | 1.764M |
| October 09, 2026 | 2.137M |
| October 08, 2026 | 2.550M |
| October 07, 2026 | 2.786M |
| October 06, 2026 | 2.740M |
| October 05, 2026 | 2.799M |
| October 02, 2026 | 2.738M |
| October 01, 2026 | 2.779M |
| September 30, 2026 | 2.966M |
| September 29, 2026 | 3.111M |
| September 28, 2026 | 3.351M |
| September 25, 2026 | 3.586M |
| September 24, 2026 | 3.541M |
| September 23, 2026 | 3.590M |
| September 22, 2026 | 3.869M |
| September 21, 2026 | 3.482M |
| September 18, 2026 | 4.264M |
| September 17, 2026 | 3.957M |
| September 16, 2026 | 2.419M |
| September 15, 2026 | 2.876M |
| September 14, 2026 | 3.586M |
| September 11, 2026 | 3.595M |
| September 10, 2026 | 4.246M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 182.43M |
| Perspective Therapeutics, Inc. | 89.06M |
| MiMedx Group, Inc. | 464.04M |
| Veracyte, Inc. | 2.062B |
| T2 Biosystems, Inc. | 0.0113M |
Market Cap Related Metrics
| PS Ratio | 0.1794 |
| Price to Book Value | 0.6407 |
| Price | 2.15 |
| Earnings Yield | -1.77K% |